市場調査レポート
商品コード
1184200

バイオプリンティング:各種技術と世界市場

Bioprinting: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 105 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
バイオプリンティング:各種技術と世界市場
出版日: 2023年01月06日
発行: BCC Research
ページ情報: 英文 105 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオプリンティングの市場規模は、2022年の24億米ドルから、2027年には50億米ドルに成長し、2022年から2027年にかけてのCAGRは16.2%と予測されています。

液滴配置の部門は、2022年の9億790万米ドルから、2027年には20億米ドルに成長し、2022年から2027年にかけてのCAGRは17.5%と予測されています。また、光重合の部門は、2022年の5億7,460万米ドルから、2027年には12億米ドルに成長し、CAGRは16.2%と予測されています。

当レポートでは、世界のバイオプリンティングの市場を調査し、市場概要、技術動向、関連法規制、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

  • バイオプリンティング製品のライフサイクル
  • バイオプリンティング産業
  • バイオプリンティング機器技術
    • ソフトウェア
    • Organ-on-a-chip
  • 臓器とオルガノイド
    • オルガノイド
    • 臓器
  • 臓器プリンティングの技術的課題
  • バイオプリンティングの用途
  • 医療・ヘルスケア製品のイノベーション
  • 現在の動向
  • 規制・法律

第4章 市場力学

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 戦略
    • 動向

第5章 COVID-19の影響

第6章 世界のバイオプリンティング市場:技術別

  • 概要
  • 液滴配置
  • 光重合

第7章 世界のバイオプリンティング市場:エンドユーザー別

  • 概要
  • 創薬・開発
  • 研究
  • 化粧品
  • その他

第8章 世界のバイオプリンティング技術市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 競合情勢

第10章 企業プロファイル

  • 3D BIO CORP.
  • 3D BIOPRINTING SOLUTIONS
  • 3D SYSTEMS INC.
  • ADVANCED SOLUTIONS INC.
  • ASPECT BIOSYSTEMS LTD.
  • CELLINK
  • CYFUSE BIOMEDICAL
  • COLLPLANT BIOTECHNOLOGIES LTD.
  • ORGANOVO HOLDING INC.
  • PRECISE BIO
  • STRATASYS LTD.
  • その他の企業
図表

List of Tables

  • Summary Table : Global Market for Bioprinting Technologies, by Type, Through 2027
  • Table 1 : Life Cycle of Bioprinting Products
  • Table 2 : Characteristics of Bioprinting Industry Segments
  • Table 3 : Comparison of Bioprinting with 3D Printing
  • Table 4 : Bioprinting Instrument Technologies
  • Table 5 : Public Policy Issues Related to Bioprinted Organs
  • Table 6 : Bioprinting of Organs: Technological Challenges
  • Table 7 : Bioprinting Applications
  • Table 8 : Class I and II Exempt Devices
  • Table 9 : Applications of Bioprinting in Cancer Tissue Engineering
  • Table 10 : 3D Bioprinting Technologies in Development for COVID-19 Vaccines and Therapeutics
  • Table 11 : Global Market for Bioprinting Technologies, by Type, Through 2027
  • Table 12 : Global Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
  • Table 13 : Global Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
  • Table 14 : Global Market for Bioprinting Technologies, by End Use, Through 2027
  • Table 15 : 3D Printed Drug Delivery Systems
  • Table 16 : Global Market for Bioprinting Technologies, by Region, Through 2027
  • Table 17 : North American Market for Bioprinting Technologies, by Type, Through 2027
  • Table 18 : North American Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
  • Table 19 : North American Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
  • Table 20 : North American Market for Bioprinting Technologies, by End Use, Through 2027
  • Table 21 : North American Market for Bioprinting Technologies, by Country, Through 2027
  • Table 22 : European Market for Bioprinting Technologies, by Type, Through 2027
  • Table 23 : European Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
  • Table 24 : European Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
  • Table 25 : European Market for Bioprinting Technologies, by End Use, Through 2027
  • Table 26 : European Market for Bioprinting Technologies, by Country, Through 2027
  • Table 27 : Asia-Pacific Market for Bioprinting Technologies, by Type, Through 2027
  • Table 28 : Asia-Pacific Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
  • Table 29 : Asia-Pacific Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
  • Table 30 : Asia-Pacific Market for Bioprinting Technologies, by End Use, Through 2027
  • Table 31 : Asia-Pacific Market for Bioprinting Technologies, by Country, Through 2027
  • Table 32 : Rest of the World Market for Bioprinting Technologies, by Type, Through 2027
  • Table 33 : Rest of the World Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
  • Table 34 : Rest of the World Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
  • Table 35 : Rest of the World Market for Bioprinting Technologies, by End Use, Through 2027
  • Table 36 : Rest of the World Market for Bioprinting Technologies, by Country, Through 2027
  • Table 37 : Recent Developments in the Global Market for Bioprinting Technologies, 2018-2022
  • Table 38 : 3D Bio Corp.: Product Portfolio
  • Table 39 : 3D Bio Corp.: Recent Developments, 2022
  • Table 40 : 3D Bioprinting Solutions: Product Portfolio
  • Table 41 : 3D Bioprinting Solutions: Recent Developments, 2014-2021
  • Table 42 : 3D Systems, Inc.: Product Portfolio
  • Table 43 : 3D Systems, Inc.: Recent Developments, 2020-2022
  • Table 44 : Advanced Solutions Inc.: Product Portfolio
  • Table 45 : Advanced Solutions Inc.: Recent Developments, 2019-2021
  • Table 46 : Aspect Biosystems Ltd.: Product Portfolio
  • Table 47 : Aspect Biosystems Ltd.: Recent Developments, 2019-2022
  • Table 48 : Cellink: Product Portfolio
  • Table 49 : Cellink: Recent Developments, 2022
  • Table 50 : Cyfuse Biomedical: Product Portfolio
  • Table 51 : Cyfuse Biomedical: Recent Developments, 2019-2021
  • Table 52 : CollPlant: Product Portfolio
  • Table 53 : CollPlant: Recent Developments, 2022
  • Table 54 : Organovo: Product Portfolio
  • Table 55 : Organovo: Recent Developments, 2022
  • Table 56 : Precise Bio: Product Portfolio
  • Table 57 : Precise Bio: Recent Developments, 2018-2022
  • Table 58 : Stratasys Ltd.: Product Portfolio
  • Table 59 : Stratasys Ltd.: Recent Developments, 2022
  • Table 60 : Other Bioprinting Startups

List of Figures

  • Summary Figure : Global Market for Bioprinting Technologies, by Type, 2019-2027
  • Figure 1 : Medical Device Marketing Process in the U.S.
  • Figure 2 : Global Population Aging 60+ Years, by Region, 2015-2050
  • Figure 3 : Global Projected Diabetes Patients Aged 20-79, 2010 and 2030
  • Figure 4 : Workflow Structure and Emergency Use Authorization of 3D Printed Products
  • Figure 5 : Global Market Shares of Bioprinting Technologies, by Type, 2021
  • Figure 6 : Global Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
  • Figure 7 : Global Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
  • Figure 8 : Global Market Shares of Bioprinting Technologies, by End Use, 2021
  • Figure 9 : Drug Discovery Pipeline with Retooling 3D Printing Technologies
  • Figure 10 : North American Market Shares of Bioprinting Technologies, by Type, 2021
  • Figure 11 : North American Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
  • Figure 12 : North American Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
  • Figure 13 : North American Market Shares of Bioprinting Technologies, by End Use, 2021
  • Figure 14 : North American Market Shares of Bioprinting Technologies, by Country, 2021
  • Figure 15 : U.S. Elderly (65+ Years) Population, 2010-2050
  • Figure 16 : European Market Shares of Bioprinting Technologies, by Type, 2021
  • Figure 17 : European Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
  • Figure 18 : European Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
  • Figure 19 : European Market Shares of Bioprinting Technologies, by End Use, 2021
  • Figure 20 : European Market Shares of Bioprinting Technologies, by Country, 2021
  • Figure 21 : Asia-Pacific Market Shares of Bioprinting Technologies, by Type, 2021
  • Figure 22 : Asia-Pacific Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
  • Figure 23 : Asia-Pacific Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
  • Figure 24 : Asia-Pacific Market Shares of Bioprinting Technologies, by End Use, 2021
  • Figure 25 : Asia-Pacific Market Shares of Bioprinting Technologies, by Country, 2021
  • Figure 26 : Rest of the World Market Shares of Bioprinting Technologies, by Type, 2021
  • Figure 27 : Rest of the World Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
  • Figure 28 : Rest of the World Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
  • Figure 29 : Rest of the World Market Shares of Bioprinting Technologies, by End Use, 2021
  • Figure 30 : Rest of the World Market Shares of Bioprinting Technologies, by Country, 2021
  • Figure 31 : Bioprinting Company Ranking Analysis, 2021
  • Figure 32 : Top Bioprinting Startups Ranking, 2021
目次
Product Code: BIO148B

Highlights:

The global bioprinting technologies market should reach $5.0 billion by 2027 from $2.4 billion in 2022 at a compound annual growth rate (CAGR) of 16.2% for the forecast period of 2022 to 2027.

Droplet disposition segment of the global bioprinting technologies market is expected to grow from $907.9 million in 2022 to $2.0 billion in 2027 at a CAGR of 17.5% for the forecast period of 2022 to 2027.

Photopolymerization segment of the global bioprinting technologies market is expected to grow from $574.6 million in 2022 to $1.2 billion in 2027 at a CAGR of 16.2% for the forecast period of 2022 to 2027.

Report Scope:

This report incorporates an in-depth analysis of the bioprinting market, including market estimations and trends through 2020. Major players, competitive intelligence, innovative technologies, market dynamics, and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for bioprinting technologies.

The scope of the report extends to only those bioprinting technologies that generate the most global revenue. Surgical device or guides and ceramics or metal devices used in 3D bioprinting overlap with other products that are already covered under the technology segments, so these have been excluded.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World region. For market estimates, data is provided for 2020, as the base year 2021 and forecast through year-end 2027.

Report Includes:

  • 26 data tables and 35 additional tables
  • An up-to-date review and analysis of the global markets for bioprinting technologies and applications within the industry
  • Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of market opportunities for this innovation-driven market, and the major regions and countries involved in market developments
  • Estimation of the actual market size and revenue forecast for global bioprinting market in USD millions, and corresponding market share analysis by type of technology, application, end-user, and region
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market for bioprinting over the forecast period (2022 to 2027)
  • Analysis of the markets for the main bioprinting end-use applications, including research, drug discovery and development, cosmetics, and clinical
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on technologies, applications, and end users of bioprinting
  • Updated information on recent industry acquisitions, partnerships, agreements, collaborations, and other strategic alliances in the global bioprinting market
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Profile descriptions of the market leading participants, including 3D Bio Corp., Advanced Solutions Inc., Cellink, Organovo, and Stratasys Ltd.

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing This Study
  • 1.3 What's New in This Report?
  • 1.4 Scope of Report
  • 1.5 Information Sources
  • 1.6 Methodology
  • 1.7 Geographic Breakdown
  • 1.8 Analyst's Credentials
  • 1.9 BCC Custom Research
  • 1.10 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • 3.1 Bioprinting Product Life Cycle
  • 3.2 Bioprinting Industry
  • 3.3 Bioprinting Instrument Technologies
    • 3.3.1 Software
    • 3.3.2 Organ-On-Chip
  • 3.4 Organs and Organoids
    • 3.4.1 Organoids
    • 3.4.2 Organs
  • 3.5 Technological Challenges in Printing Organs
  • 3.6 Bioprinting Applications
  • 3.7 Innovations in Medical/Healthcare Products
    • 3.7.1 Diagnosing Diseases
    • 3.7.2 Monitoring Patients
    • 3.7.3 Personalized Medicine
  • 3.8 Current Trends
    • 3.8.1 Enhanced Cybersecurity
    • 3.8.2 Internet of Medical Things (IoMT)
    • 3.8.3 Medical Robots
    • 3.8.4 3D Printed Objects
    • 3.8.5 Device Connectivity
  • 3.9 Regulations and Legislation
    • 3.9.1 Europe
    • 3.9.2 U.S.
    • 3.9.3 Japan

Chapter 4 Market Dynamics

  • 4.1 Market Dynamics
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Strategies
    • 4.1.5 Trends

Chapter 5 Impact of the COVID-19 Pandemic

  • 5.1 Impact of COVID-19 on the Market for Bioprinting
    • 5.1.1 Personal Protective Equipment (PPE)
    • 5.1.2 Face Masks
    • 5.1.3 Face Shields
    • 5.1.4 3D Printing in Healthcare

Chapter 6 Global Market for Bioprinting Technologies

  • 6.1 Overview
  • 6.2 Droplet Disposition
    • 6.2.1 Market Outlook
  • 6.3 Photopolymerization
    • 6.3.1 Market Outlook

Chapter 7 Global Market for Bioprinting End Uses

  • 7.1 Overview
  • 7.2 Drug Discovery and Development
    • 7.2.1 Market Outlook
  • 7.3 Research
  • 7.4 Cosmetics
  • 7.5 Other End Uses

Chapter 8 Global Market for Bioprinting Technologies by Region

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 Market Outlook
  • 8.3 Europe
    • 8.3.1 Market Outlook
  • 8.4 Asia-Pacific
    • 8.4.1 Market Outlook
  • 8.5 Rest of the World
    • 8.5.1 Market Outlook

Chapter 9 Competitive Landscape

Chapter 10 Company Profiles

  • 3D BIO CORP.
  • 3D BIOPRINTING SOLUTIONS
  • 3D SYSTEMS INC.
  • ADVANCED SOLUTIONS INC.
  • ASPECT BIOSYSTEMS LTD.
  • CELLINK
  • CYFUSE BIOMEDICAL
  • COLLPLANT BIOTECHNOLOGIES LTD.
  • ORGANOVO HOLDING INC.
  • PRECISE BIO
  • STRATASYS LTD.
  • Other Companies